XML 77 R58.htm IDEA: XBRL DOCUMENT v3.3.1.900
Guarantor Condensed Consolidating Financial Information (Tables)
12 Months Ended
Dec. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of impact of revisions
Condensed Consolidating Statements of Comprehensive (Loss) Income:
Parent
Issuer
Guarantor
Subsidiaries
Non-Guarantor
Subsidiaries
Eliminations and 
Adjustments
As
Reported
As
Revised
As 
Reported
As 
Revised
As 
Reported
As 
Revised
As 
Reported
As 
Revised
Year Ended December 31, 2015
Net sales
$ $ $ 4,067 $ 4,044 $ 3,200 $ 3,269 $ (1,550) $ (1,596)
Cost of goods sold
4,123 3,708 2,246 2,650 (1,607) (1,596)
Gross (loss) profit
(56) 336 954 619 57
Selling, general and administrative expense
15 15 460 426 170 204 (13) (13)
Equity in earnings of subsidiaries
(15) (47) 15 47
Interest expense and other income, net
(106) (74) 192 91 (107) (75) (57) (20)
(Loss) income before income taxes
(136) (136) (734) (413) 654 321 28 40
(Benefit from) provision for income taxes
(46) (46) (114) (89) 54 40 8 (3)
Net (loss) income
(90) (90) (620) (324) 600 281 20 43
Comprehensive (loss) income attributable to Chemours
(82) (82) (620) (324) 348 29 20 43
Condensed Consolidating Statements of Cash Flows:
Parent 
Issuer
Guarantor 
Subsidiaries
Non-Guarantor 
Subsidiaries
Eliminations and 
Adjustments
As 
Reported
As 
Revised
As 
Reported
As 
Revised
As 
Reported
As 
Revised
As 
Reported
As
Revised
Year Ended December 31, 2015
Cash flows from operating activities
$ (119) $ (119) $ (125) $ 171 $ 440 $ 121 $ (14) $ 9
Cash flows from investing activities
(446) (446) (253) (253) 202 202
Cash flows from financing activities
119 119 666 370 90 409 (188) (211)
Schedule of condensed consolidating statements of comprehensive (loss) Income
Condensed Consolidating Statements of Comprehensive (Loss) Income
Year Ended December 31, 2015
Parent Issuer
Guarantor 
Subsidiaries
Non-Guarantor 
Subsidiaries
Eliminations 
and 
Adjustments
Consolidated
Net sales
$ $ 4,044 $ 3,269 $ (1,596) $ 5,717
Cost of goods sold
3,708 2,650 (1,596) 4,762
Gross (loss) profit
336 619 955
Selling, general and administrative expense
15 426 204 (13) 632
Research and development expense
95 2 97
Employee separation and asset related charges, 
net
295 38 333
Goodwill impairment
25 25
Total expenses
15 841 244 (13) 1,087
Equity in earnings of affiliates
1 21 22
Equity in net loss of subsidiaries
(47) 47
Interest expense, net
(131) (1) (132)
Intercompany interest income (expense), net
44 (44)
Other income (loss), net
13 92 (31) (20) 54
(Loss) income before income taxes
(136) (413) 321 40 (188)
(Benefit from) provision for income taxes
(46) (89) 40 (3) (98)
Net (loss) income
(90) (324) 281 43 (90)
Less: Net income attributable to noncontrolling interests
Net (loss) income attributable to Chemours
$ (90) $ (324) $ 281 $ 43 $ (90)
Comprehensive (loss) income attributable to Chemours
$ (82) $ (324) $ 29 $ 43 $ (334)

  
Condensed Consolidating Statements of Comprehensive Income
Year Ended December 31, 2014
Parent Issuer
Guarantor 
Subsidiaries
Non-Guarantor 
Subsidiaries
Eliminations 
and 
Adjustments
Consolidated
Net sales
$ $ 4,593 $ 3,722 $ (1,883) $ 6,432
Cost of goods sold
3,863 3,093 (1,884) 5,072
Gross profit
730 629 1 1,360
Selling, general and administrative expense
429 256 685
Research and development expense
127 16 143
Employee separation and asset related charges, net
11 10 21
Total expenses
567 282 849
Equity in earnings of affiliates
20 20
Equity in earnings of subsidiaries
400 (400)
Other income (expense), net
80 (61) 19
Income before income taxes
400 243 306 (399) 550
Provision for income taxes
75 76 (2) 149
Net income
400 168 230 (397) 401
Less: Net income attributable to noncontrolling interests
1 1
Net income attributable to Chemours
$ 400 $ 168 $ 229 $ (397) $ 400
Comprehensive income attributable to Chemours
$ 400 $ 168 $ 229 $ (397) $ 400
Condensed Consolidating Statements of Comprehensive Income
Year Ended December 31, 2013
Parent Issuer
Guarantor 
Subsidiaries
Non-Guarantor 
Subsidiaries
Eliminations 
and 
Adjustments
Consolidated
Net sales
$ $ 5,066 $ 3,690 $ (1,897) $ 6,859
Cost of goods sold
4,250 3,053 (1,908) 5,395
Gross profit
816 637 11 1,464
Selling, general and administrative expense
492 276 768
Research and development expense
147 17 164
Employee separation and asset related charges, net
2 2
Total expenses
639 295 934
Equity in earnings of affiliates
22 22
Other income (expense), net
48 (24) 24
Income before income taxes
225 340 11 576
Provision for income taxes
72 77 3 152
Net income
153 263 8 424
Less: Net income attributable to noncontrolling interests
1 1
Net income attributable to Chemours
$ $ 153 $ 262 $ 8 $ 423
Comprehensive income attributable to Chemours
$ $ 153 $ 262 $ 8 $ 423
Schedule of condensed consolidating balance sheets
Condensed Consolidating Balance Sheets
Year Ended December 31, 2015
Parent Issuer
Guarantor 
Subsidiaries
Non-Guarantor 
Subsidiaries
Eliminations 
and 
Adjustments
Consolidated
Assets
Current assets:
Cash
$ $ 95 $ 271 $ $ 366
Accounts and notes receivable–trade, 
net
344 515 859
Intercompany receivable
3 459 54 (516)
Inventories
493 501 (22) 972
Prepaid expenses and other
49 52 3 104
Total current assets
3 1,440 1,393 (535) 2,301
Property, plant and equipment
7,070 1,945 9,015
Less: Accumulated depreciation
(4,899) (939) (5,838)
Net property, plant and equipment
2,171 1,006 3,177
Goodwill 141 25 166
Other intangible assets, net
10 10
Investments in affiliates
9 127 136
Investment in subsidiaries
3,105 (3,105)
Intercompany notes receivable
1,150 (1,150)
Other assets
19 275 214 508
Total assets
$ 4,277 $ 4,046 $ 2,765 $ (4,790) $ 6,298
Liabilities and equity
Current liabilities:
Accounts payable
$ $ 637 $ 336 $ $ 973
Short-term borrowings and current maturities of long-term debt
15 24 39
Intercompany payable
202 54 260 (516)
Other accrued liabilities
21 287 146 454
Total current liabilities
238 1,002 742 (516) 1,466
Long-term debt
3,913 2 3,915
Other liabilities
456 97 553
Intercompany notes payable
1,150 (1,150)
Deferred income taxes
173 61 234
Total liabilities
4,151 1,633 2,050 (1,666) 6,168
Commitments and contingent liabilities
Equity
Total Chemours stockholder’s equity
126 2,413 711 (3,124) 126
Noncontrolling interests
4 4
Total equity
126 2,413 715 (3,124) 130
Total liabilities and equity
$ 4,277 $ 4,046 $ 2,765 $ (4,790) $ 6,298

Condensed Consolidating Balance Sheets
Year Ended December 31, 2014
Parent Issuer
Guarantor 
Subsidiaries
Non-Guarantor 
Subsidiaries
Eliminations 
and 
Adjustments
Consolidated
Assets
Current assets:
Cash
$ $ $ $ $
Accounts and notes receivable–trade, 
net
355 491 846
Intercompany receivable
316 42 (358)
Inventories
510 616 (74) 1,052
Prepaid expenses and other
12 16 15 43
Total current assets
1,193 1,165 (417) 1,941
Property, plant and equipment
7,107 2,175 9,282
Less: Accumulated depreciation
(4,848) (1,126) (5,974)
Net property, plant and equipment
2,259 1,049 3,308
Goodwill 170 28 198
Other intangible assets, net
11 11
Investments in affiliates
124 124
Investments in subsidiaries
3,669 (3,669)
Other assets
332 45 377
Total assets
$ 3,669 $ 3,965 $ 2,411 $ (4,086) $ 5,959
Liabilities and equity
Current liabilities:
Accounts payable
$ $ 614 $ 432 $ $ 1,046
Intercompany payable
42 316 (358)
Other accrued liabilities
248 104 352
Total current liabilities
904 852 (358) 1,398
Other liabilities
454 10 464
Deferred income taxes
380 44 424
Total liabilities
1,738 906 (358) 2,286
Commitments and contingent liabilities
Equity
Total Chemours stockholder’s equity
3,669 2,227 1,501 (3,728) 3,669
Noncontrolling interests
4 4
Total equity
3,669 2,227 1,505 (3,728) 3,673
Total liabilities and equity
$ 3,669 $ 3,965 $ 2,411 $ (4,086) $ 5,959
Schedule of condensed consolidating statements of cash flows
Condensed Consolidating Statements of Cash Flows
Year Ended December 31, 2015
Parent Issuer
Guarantor 
Subsidiaries
Non-Guarantor 
Subsidiaries
Eliminations 
and 
Adjustments
Consolidated
Operating activities
Cash (used for) provided by operating activities
$ (119) $ 171 $ 121 $ 9 $ 182
Investing activities
Purchases of property, plant and equipment
(292) (227) (519)
Proceeds from sales of assets, net
6 6 12
Foreign exchange contract settlements
42 42
Investment in affiliates
(32) (32)
Intercompany investing activities
(202) 202
Cash used for investing activities
(446) (253) 202 (497)
Financing activities
Proceeds from issuance of debt, net
3,489 2 3,491
Intercompany short-term borrowings, net
202 (202)
Debt repayments
(8) (2) (10)
Dividends paid
(105) (105)
Debt issuance costs
(79) (79)
Cash provided at separation by DuPont
87 160 247
Net transfers (to) from DuPont
(3,380) 283 249 (9) (2,857)
Cash provided by financing activities
119 370 409 (211) 687
Effect of exchange rate changes on cash
(6) (6)
Increase in cash
95 271 366
Cash at beginning of year
Cash at end of year
$ $ 95 $ 271 $ $ 366

 
Condensed Consolidating Statements of Cash Flows
Year Ended December 31, 2014
Parent Issuer
Guarantor 
Subsidiaries
Non-Guarantor 
Subsidiaries
Eliminations 
and 
Adjustments
Consolidated
Operating activities
Cash provided by operating activities
$ $ 302 $ 208 $ (5) $ 505
Investing activities
Purchases of property, plant and equipment
(287) (317) (604)
Proceeds from sales of assets, net
30 2 32
Investment in affiliates
(8) (8)
Other investing activities
20 20
Cash used for investing activities
(237) (323) (560)
Financing activities
Net transfers (to) from DuPont
(65) 115 5 55
Cash (used for) provided by financing activities
(65) 115 5 55
Effect of exchange rate changes on cash
Increase in cash
Cash at beginning of year
Cash at end of year
$ $ $ $ $
Year Ended December 31, 2013
Parent Issuer
Guarantor 
Subsidiaries
Non-Guarantor 
Subsidiaries
Eliminations 
and 
Adjustments
Consolidated
Operating activities
Cash provided by operating activities
$ $ 388 $ 409 $ 1 $ 798
Investing activities
Purchases of property, plant and equipment
(200) (238) (438)
Proceeds from sales of assets, net
8 6 14
Cash used for investing activities
(192) (232) (424)
Financing activities
Net transfers to DuPont
(196) (177) (1) (374)
Cash used for financing activities
(196) (177) (1) (374)
Effect of exchange rate changes on cash
Increase in cash
Cash at beginning of year
Cash at end of year
$ $ $ $ $